Pedunculopontine Nucleus Transcranial Ultrasound Stimulation as a Treatment of Freezing of Gait in Parkinson's Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-90
SponsorRobert Chen

About this trial

This study is investigating the use of transcranial ultrasound stimulation (TUS) on the Pedunculopontine nucleus (PPN) in changing freezing of gait in people with Parkinson's disease. The PPN is noted to be involved in voluntary movements, locomotion, and muscle tone. This will be assessed by patient-reported outcomes and analyzing the gait. The study will also investigate the effects of the stimulation on the PPN and surrounding connectivity by using magnetic resonance imaging (MRI).

Eligibility criteria

Qualifiers

18-90 years of age

Confirmed diagnosis of a movement disorder with Freezing of Gait

Stable dopaminergic medication dose for a minimum of 4 weeks

Disqualifiers

History of stroke or seizure

Comorbid dementia

Scored below 22 on the Montreal Cognitive Assessment (MoCA)

Has intracranial implant(s) or device(s)

Trial design

Treatments tested in this trial

  • Excitatory Stimulation
  • Inhibitory Stimulation
  • Sham

Treatment groups

50 Participants
are divided into 1 treatment group

Sponsors and collaborators

Robert Chen

Lead sponsor

University Health Network, Toronto

Sponsor institution